Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Gene Therapy

• Publication date

  1999-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3300862PMID 10476215
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic cells and the control of immunity

  1998cited by this paper
• Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.

  1998cited by this paper
• Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects.

  1998cited by this paper
• Gene therapy in the treatment of autoimmune disease.

  1998cited by this paper
• Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig

  1998cited by this paper
• Local Delivery of Interleukin 4 by Retrovirus-Transduced T Lymphocytes Ameliorates Experimental Autoimmune Encephalomyelitis

  1997cited by this paper
• Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin‐10

  1997cited by this paper
• CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.

  1997cited by this paper
• Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow.

  1997cited by this paper
• Contrasting Effects of TGF‐β1 and TNF‐α on the Development of Dendritic Cells from Progenitors in Mouse Bone Marrow

  1997cited by this paper
• Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity

  1997cited by this paper
• Induction of tolerance by IL-10-treated dendritic cells.

  1997cited by this paper
• Treatment of Experimental Autoimmune Encephalomyelitis with Genetically Modified Memory T Cells

  1997cited by this paper
• Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.

  1997cited by this paper
• Effect of interleukin‐10 on dendritic cell maturation and function

  1997cited by this paper
• Construction of adenovirus vectors through Cre-lox recombination

  1997cited by this paper
• Gene therapy - promises, problems and prospects

  1997cited by this paper
• Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.

  1997cited by this paper
• Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

  1997cited by this paper
• Adenovirus-mediated gene transfer in the transplant setting: early events after orthotopic transplantation of liver allografts expressing TGF-beta1.

  1996cited by this paper
• Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat.

  1996cited by this paper
• Gene therapy in transplantation.

  1996cited by this paper
• Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion.

  1996cited by this paper
• Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy.

  1996cited by this paper
• Dendritic cells and tolerance induction

  1996cited by this paper
• Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.

  1996cited by this paper
• Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1).

  1996cited by this paper
• A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand- induced apoptosis

  1996cited by this paper
• Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.

  1996cited by this paper
• Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival.

  1996cited by this paper
• Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis.

  1996cited by this paper
• Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?

  1995cited by this paper
• Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony- stimulating factor

  1995cited by this paper
• Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival.

  1995cited by this paper
• Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes.

  1995cited by this paper
• CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2

  1995cited by this paper
• In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation.

  1995cited by this paper
• Transduction of hepatic allografts achieves local levels of viral IL-10 which suppress alloreactivity in vitro.

  1995cited by this paper
• New perspectives of CD28-B7-mediated T cell costimulation.

  1995cited by this paper
• Microchimerism, dendritic cell progenitors and transplantation tolerance

  1995cited by this paper
• GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival

  1995cited by this paper
• New perspectives of C1328-137-mediated T cell costimulation

  1995cited by this paper
• Propagation of dendritic cell progenitors from normal mouse liver using GM-CSF and their maturational development in the presence of type-I collagen

  1994cited by this paper
• Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen

  1994cited by this paper
• Transplantation tolerance induced by CTLA4-Ig.

  1994cited by this paper
• Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex.

  1994cited by this paper
• In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients

  1994cited by this paper
• Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.

  1993cited by this paper
• The role of the CD28 receptor during T cell responses to antigen.

  1993cited by this paper
• Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene.

  1993cited by this paper
• Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

  1993cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.

  1992cited by this paper
• Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells.

  1991cited by this paper
• The dendritic cell system and its role in immunogenicity.

  1991cited by this paper
• CTLA-4 is a second receptor for the B cell activation antigen B7

  1991cited by this paper
• Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes

  1988cited by this paper

• GRAS-microparticle microarrays identify dendritic cell tolerogenic marker-inducing formulations.

  2021cites this paper
• Dendritic cells transduced with TIPE-2 recombinant adenovirus induces T cells suppression

  2020cites this paper
• Immune checkpoints and the regulation of tolerogenicity in dendritic cells: Implications for autoimmunity and immunotherapy.

  2019cites this paper
• Tolerising cellular therapies: what is their promise for autoimmune disease?

  2018cites this paper
• Regulatory dendritic cells: profiling, targeting, and therapeutic application

  2018cites this paper
• Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells

  2018cites this paper
• Role of innate immunity in tolerance induction

  2015cites this paper
• The role of innate immunity in induction of tolerance

  2015cites this paper
• [Role of innate immunity in tolerance induction].

  2015cites this paper
• Rapamycin-conditioned dendritic cells activated with monophosphoryl lipid-A promote allograft acceptance in vivo.

  2015cites this paper
• DC-Based Immunotherapy Combined with Low-Dose Methotrexate Effective in the Treatment of Advanced CIA in Mice

  2015cites this paper
• Protective effects of Fc-fused PD-L1 on two different animal models of colitis

  2014cites this paper
• Development and optimization of a workflow to enable mass spectrometry-based quantitative membrane proteomics of mature and tolerogenic dendritic cells

  2014cites this paper
• Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis

  2013cites this paper
• Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?

  2013cites this paper
• Zinc finger protein A20 inhibits maturation of dendritic cells resident in rat liver allograft.

  2013cites this paper
• Dendritic Cell-Based Approaches for Therapeutic Immune Regulation in Solid-Organ Transplantation

  2013cites this paper
• Gene and Cell Therapies for Diabetes Mellitus

  2012cites this paper
• CD40 and tolerance induction.

  2012cites this paper
• Tolerance-Inducing Strategies in Islet Transplantation

  2012cites this paper
• Dendritic cell therapy for Type 1 diabetes suppression.

  2012cites this paper
• Cytotoxic T lymphocyte antigen 4 immunoglobulin modified dendritic cells attenuate allergic airway inflammation and hyperresponsiveness by regulating the development of T helper type 1 (Th1)/Th2 and Th2/regulatory T cell subsets in a murine model of asthma

  2011cites this paper
• Dendritic cells transfected with PD-L1 recombinant adenovirus induces T cell suppression and long-term acceptance of allograft transplantation.

  2011cites this paper
• Current State of Type 1 Diabetes Immunotherapy: Incremental Advances, Huge Leaps, or More of the Same?

  2011cites this paper
• Dendritic cell control of tolerogenic responses

  2011cites this paper
• Tolerogenic Dendritic Cells in Clinical Practice

  2010cites this paper
• Induction of T cells suppression by dendritic cells transfected with VSIG4 recombinant adenovirus.

  2010cites this paper
• Development of Dendritic Cell-Based Immunotherapy for Autoimmunity

  2010cites this paper
• CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.

  2010cites this paper
• Regulation of Immune Responses by Genetically-Engineered Dendritic Cells and Exosomes

  2010cites this paper
• Dendritic cell-based therapy in Type 1 diabetes mellitus

  2009cites this paper
• The immunologic properties of undifferentiated and osteogenic differentiated mouse mesenchymal stem cells and its potential application in bone regeneration.

  2009cites this paper
• Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties.

  2008cites this paper
• Immunomodulatory and osteogenic differentiation effects of mesenchymal stem cells by adenovirus‐mediated coexpression of CTLA4Ig and BMP2

  2008cites this paper
• Innate and adaptive immune responses in tissue engineering.

  2008cites this paper
• Use of dendritic cells in drug selection, development and therapy

  2008cites this paper
• Dendritic cells in transplant tolerance.

  2007cites this paper
• Induction by RelB-Silenced Dendritic Cells Immune Modulation and Tolerance

  2007cites this paper
• Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus

  2007cites this paper
• Immune Modulation and Tolerance Induction by RelB-Silenced Dendritic Cells through RNA Interference1

  2007cites this paper
• Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.

  2007cites this paper
• Dendritic cells as promoters of transplant tolerance

  2006cites this paper
• Pulmonary Immunity to Viral Infection: Adenovirus Infection of Lung Dendritic Cells Renders T Cells Nonresponsive to Interleukin-2

  2006cites this paper
• Modified to Express Soluble TNF Receptor Immature Dendritic Cells Genetically Induction of Allospecific Tolerance by

  2006cites this paper
• Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.

  2006cites this paper
• Induction of Allospecific Tolerance by Immature Dendritic Cells Genetically Modified to Express Soluble TNF Receptor1

  2006cites this paper
• Langerhans-Type Dendritic Cells Genetically Modified to Express Full-Length Antigen Optimally Stimulate CTLs in a CD4-Dependent Manner1

  2006cites this paper
• DENDRITIC CELLS-A POTENTIAL TOOL FOR TOLERANCE INDUCTION IN ORGAN TRANSPLANTATION

  2005cites this paper
• Prevention of Experimental Autoimmune Encephalomyelitis by Transfer of Embryonic Stem Cell-Derived Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein Peptide along with TRAIL or Programmed Death-1 Ligand1

  2005cites this paper
• Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization

  2005cites this paper
• The evolving role of gene‐based treatment in surgery

  2005cites this paper
• Peptide along with TRAIL or Programmed Myelin Oligodendrocyte Glycoprotein Stem Cell-Derived Dendritic Cells Expressing Encephalomyelitis by Transfer of Embryonic Prevention of Experimental Autoimmune

  2005cites this paper
• Gene Therapeutics in Autoimmune Diabetes

  2005cites this paper
• Dendritic Cells in Transplantation: Origin, Immune Activation, and Allograft Tolerance

  2004cites this paper
• IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.

  2004cites this paper
• Gene- and cell-based therapeutics for type I diabetes mellitus

  2003cites this paper
• Prolonged survival of heart allografts transduced with AAV‐CTLA4Ig

  2003cites this paper
• Current Status and Prospects for Gene and Cell Therapeutics for Type 1 Diabetes Mellitus

  2003cites this paper
• Suppression of Allogeneic Response by Viral IL-10 Gene Transfer

  2003cites this paper
• Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection

  2003cites this paper
• Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin

  2003cites this paper
• Gene therapy technology applied to disorders of glucose metabolism: promise, achievements, and prospects.

  2003cites this paper
• Dendritic Cells Transduced to Express Interleukin-4 Prevent Diabetes in Nonobese Diabetic Mice with Advanced Insulitis

  2003cites this paper
• Retroviral modifizierte, alloantigen-spezifische und vIL-10 transgene T-Lymphozyten als therapeutischer Ansatz im akuten Abstoßungsmodell

  2003cites this paper
• Adenoviral Vectors for Gene Delivery

  2003cites this paper
• Islet/pancreas transplantation: challenges for pediatrics

  2002cites this paper
• Therapeutic strategies for Type 1 and Type 2 diabetes mellitus.

  2002cites this paper
• Retroviral delivery of transforming growth factor-&bgr;1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival12

  2002cites this paper
• MANIPULATION OF DENDRITIC CELLS FOR TOLERANCE INDUCTION IN TRANSPLANTATION AND AUTOIMMUNE DISEASE1

  2002cites this paper
• Dendritic cells: immune regulators in health and disease.

  2002cites this paper
• Manipulation of dendritic cells as an approach to improved outcomes in transplantation

  2002cites this paper
• Gene and cell therapies for diabetes mellitus: strategies and clinical potential.

  2002cites this paper
• Gene therapy and solid-organ transplantation.

  2002cites this paper
• Adenoviral Vectors Encoding CTLA 4-Ig Oligodeoxyribonucleotide Decoys and B κ Engineered with NF-Survival by Dendritic Cells Genetically Marked Prolongation of Cardiac Allograft and

  2002cites this paper
• Role of NF-κB on liver cold ischemia-reperfusion injury

  2002cites this paper
• VERSION Role of NF-B on Liver Cold Ischemia / Reperfusion Injury

  2002cites this paper
• Marked Prolongation of Cardiac Allograft Survival by Dendritic Cells Genetically Engineered with NF-κB Oligodeoxyribonucleotide Decoys and Adenoviral Vectors Encoding CTLA4-Ig1

  2002cites this paper
• Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation.

  2002cites this paper
• Designer dendritic cells for transplant tolerance.

  2002cites this paper
• TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.

  2002cites this paper
• Gene therapy in transplantation.

  2002cites this paper
• Dendritic Cells, Tolerance Induction and Transplant Outcome

  2002cites this paper
• Role of NF-kappaB on liver cold ischemia-reperfusion injury.

  2002cites this paper
• Genetic Engineering of Meniscal Allografts

  2002cites this paper
• Donor Dendritic Cells and Recipient Kupffer Cells in the Induction of Donor-Specific Immune Hyporesponsiveness

  2001cites this paper
• CHAPTER 43 – Genetic engineering of dendritic cells

  2001cites this paper
• Blockade of costimulatory molecules on dendritic cells: implications for tolerance induction.

  2001cites this paper
• Suppression of T-cell alloreactivity by gene-therapeutic modulation of human dendritic stimulator cells with TGF-beta adenoviral vectors.

  2001cites this paper
• DIFFERENTIAL EFFECTS OF MYELOID DENDRITIC CELLS RETROVIRALLY TRANSDUCED TO EXPRESS MAMMALIAN OR VIRAL INTERLEUKIN-10 ON CYTOTOXIC T LYMPHOCYTE AND NATURAL KILLER CELL FUNCTIONS AND RESISTANCE TO TUMOR GROWTH1,2

  2001cites this paper
• Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.

  2001cites this paper
• A self-immunomodulating myoblast cell line for erythropoietin delivery

  2001cites this paper
• Gene Therapy for Autoimmune Disease and Transplantation

  2001cites this paper
• Preclinical bridge to clinical tolerance

  2001cites this paper
• Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice

  2001cites this paper
• CHAPTER 42 – Dendritic cell tolerogenicity and prospects for dendritic cell-based therapy of allograft rejection and autoimmune disease

  2001cites this paper
• Potential of tolerogenic dendritic cells for transplantation.

  2001cites this paper
• STRATEGIES TO PROMOTE TOLERANCE INDUCTION USING DENDRITIC CELLS

  2001cites this paper
• Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro

  2000cites this paper
• Effects of Liver-Derived Dendritic Cell Progenitors on Th1- and Th2-Like Cytokine Responses In Vitro and In Vivo1

  2000cites this paper
• Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin‐10 on organ allograft and tumour rejection

  2000cites this paper